Provision of antiretroviral treatment in conflict settings: The experience of Médecins Sans Frontières

Conflict and Health

Volumn 4, Issue 1, 2010, Pages

  O'Brien, Daniel P ^a,b,c   Venis, Sarah ^a   Greig, Jane ^a   Shanks, Leslie ^a   Ellman, Tom ^a   Sabapathy, Kalpana ^a   Frigati, Lisa ^a,d   Mills, Clair ^a,e  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b GEELONG HOSPITAL   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79251541630     PISSN: None     EISSN: 17521505     Source Type: Journal    
DOI: 10.1186/1752-1505-4-12     Document Type: Article

References (37)

1. Prevalence of HIV infection in conflict-affected and displaced people in seven sub-Saharan African countries: a systematic review. Spiegel PB Bennedsen AR, Claass J Bruns L, Patterson N Yiweza D,, et al. Lancet 2007 369 9580 2187 95 10.1016/S0140-6736(07)61015-0 17604801 (Pubitemid 46978409)
2. A Double Emergency. Save the Children. HIV and Conflict, London 2002
3. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector Geneva. Joint United Nations Programme on HIV/AIDS (UNAIDS), 2007 http://www.who.int/hiv/mediacentre/universal-access-progress-report-en.pdf accessed July 2009
4. Geographical information system and access to HIV testing, treatment and prevention of mother-to-child transmission in conflict affected Northern Uganda. Chamla DD Olu O, Wanyana J Natseri N, Mukooyo E Okware S,, et al. Confl Health 2007 1 12 10.1186/1752-1505-1-12 18053189
5. Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens. Shannon K Kaida A, Rachlis B Lloyd-Smith E, Gray G Strathdee SA, AIDS 2008 22 1705 1707 10.1097/QAD.0b013e328308de0e 18753938
6. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Mermin J Were W, Ekwaru JP Moore D, Downing R Behumbiize P,, et al. Lancet 2008 371 9614 752 9 10.1016/S0140-6736(08)60345-1 18313504 (Pubitemid 351297773)
7. Preventing HIV transmission with antiretrovirals. De Cock KM Crowley SP Lo YR Granich RM, Williams BG,, Bulletin of the World Health Organization 2009 87 488 488 10.2471/BLT.09.067330 19649357
8. Treatment of AIDS in conflict-affected settings: a failure of imagination. Ellman T Culbert H Torres-Feced V,, Lancet 2005 365 9456 278 80 15664207 (Pubitemid 40139095)
9. Sphere humanitarian charter and minimum standards in disaster response. Geneva Sphere Project 2004 http://www.sphereproject.org/content/view/27/84 accessed August 2009
10. Guidelines for HIV/AIDS interventions in emergency settings. Inter-Agency Standing Committee (IASC), Geneva 2004
11. HIV treatment in a conflict setting: Outcomes and experiences from Bukav, Democratic Republic of the Congo. Culbert H Tu D, O'Brien DP Ellman T, Mills C Ford N,, et al. PLoS Med 2007 4 5 129 10.1371/journal.pmed.0040129 17535100
12. Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo. O'Brien DP Mills C Hamel C Ford N, Pottie K,, Conflict and Health 2009 3 1 10.1186/1752-1505-3-1 19126240
13. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. Kiboneka A Wangisi J, Nabiryo C Tembe J, Kusemererwa S Olupot-Olupot P,, et al. AIDS 2008 22 18 2493 9 10.1097/QAD.0b013e328318f148 19005272
14. Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda. Kiboneka A Nyatia RJ, Nabiryo C Anema A, Cooper CL Fernandes KA,, et al. BMJ 2009 338 201 doi: 10.1136/bmj.b201 10.1136/bmj.b201 19223338
15. Southern African HIV Clinicians Society/UNHCR. Clinical Guidelines for ART management for displaced populations Southern Africa, 2007 http://sahivsoc.org/index.php?option=com-docman&Itemid = 67 accessed August 2009
16. Towards universal access: scaling-up priority HIV/AIDS interventions in the health sector: progress report 2008. World Health Organisation, Geneva 2008
17. WHO UNHCR, UNAIDS MSF and UNICEF 19-20 September. Consensus statement, Geneva 2006
18. Epidemiological fact sheets on HIV/AIDS. Geneva: WHO http://www.who.int/ hiv/pub/epidemiology/facts/en/index.html (accessed August 2009)
19. Country specific estimates on people receiving antiretroviral therapy 2005 [xls 63 kb. Geneva:WHO http://www.who.int/hiv/data/archive/en/index.html (accessed August 2009)
20. Guidance on provider-initiated HIV testing and counseling in health facilities. World Health Organisation, Geneva 2007
21. (2009) The Evaluation of a Rapid In Situ HIV Confirmation Test in a Programme with a High Failure Rate of the WHO HIV Two-Test Diagnostic Algorithm. Klarkowski DB Wazome JM, Lokuge KM Shanks L, Mills CF O'Brien DP, PLoS ONE 4 2 4351 10.1371/journal.pone.0004351 19197370
22. Antiretroviral therapy for adults and adolescents in resource-limited settings: towards universal access. World Health Organisation, Geneva 2006
23. Tuberculosis treatment in complex emergencies: South Sudan. Hehenkamp A Hargreaves S, Lancet 2003 362 30 31 10.1016/S0140-6736(03)15066-0 14698120
24. Providing HIV care in the aftermath of Kenya's post-election violence Medecins Sans Frontieres' lessons learned January - March 2008. Reid T van Engelgem I, Telfer B Manzi M, Confl Health 2008 2 15 10.1186/1752-1505-2-15 19055803
25. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. Calmy A Pinoges L, Szumilin E Zachariah R, Ford N Ferradini L, AIDS 2006 20 8 1163 9 10.1097/01.aids. 0000226957.79847.d6 16691068 (Pubitemid 43786105)
26. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Ferradini L Jeannin A Pinoges L,,, et al. Lancet 2006 367 1335 1342 10.1016/S0140-6736(06)68580-2 16631912
27. Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2004-2007. Elema R Mills C Yun O Ssonko C, Nyirongo N Mtonga V, Zulu H Tu D, O'Brien DP,, J Int Assoc Physicians AIDS Care 2009 8 1 60 67 10.1177/1545109709331472
28. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. Boulle A Van Gustum G Hilderbrand K Cragg C, Abrahams M Mathee S, Ford N Knight L, Osler M Myers J, Goemaere E Coetzee D, Maartens G,, AIDS 2010 24 563 572 10.1097/QAD.0b013e328333bfb7 20057311
29. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups, Lancet 2006 367 817 824 10.1016/S0140-6736(06) 68337-2 16530575
30. Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene (2008). Zachariah R Van Engelgem I, Massaquoi M Kocholla L, Manzi M Suleh A,, et al. 102 288 293 18258272
31. Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya Confl Health. Vreeman RC Nyandiko WM, Sang E Musick BS, Braitstein P Wiehe SE, 2009 3 5 19344523
32. Free State? The moratorium's threat to patients' adherence and the development of drug-resistant HIV. El-Khatib Z Richter M, S Afr Med J 2009 412 414 19739316
33. The Burden of OI in Adults Receiving ART in Resource-limited Settings in Médecins Sans Frontières-supported Projects 14th Conference of Retroviruses and Opportunistic Infections, Los Angeles. Balkan S O'Brien D Humblet P Pujades M, MSF AIDS Working Group,, 2007 Abstract # 839
34. (2006) Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus,.Abidjan, Cote d'Ivoire. Chaix ML Ekouevi DK Rouet F Tonwe-Gold B, Viho I,,, et al. J Infect Dis 193 482 487 10.1086/499966 16425126 (Pubitemid 43202738)
35. Stopping antiretroviral therapy. Taylor S Boffito M Khoo S Smit E, Back D,, AIDS 2007 21 1673 1682 10.1097/QAD.0b013e3281c61394 17690564 (Pubitemid 47237553)
36. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. Dabis F Bequet L, Ekouevi DK Viho I, Rouet F Horo A,, et al. AIDS 2005 19 309 318 15718842 (Pubitemid 40396563)
37. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. O'Brien DP Sauvageot D, Zachariah R Humblet P, AIDS 2006 20 1955 60 10.1097/01.aids. 0000247117.66585.ce 16988517 (Pubitemid 44427613)